1-BUTYL-8-[4-[(4-ETHOXYCARBONYL-PIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
Compound with spectra: 1 NMR
![1-BUTYL-8-[4-[(4-ETHOXYCARBONYL-PIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE](/api/compound/CpXogXSTdyD.png?ph=true&h=300&w=458 "1-BUTYL-8-[4-[(4-ETHOXYCARBONYL-PIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE")
| SpectraBase Compound ID | CpXogXSTdyD |
|---|---|
| InChI | InChI=1S/C24H30N6O6/c1-3-5-10-30-22(32)19-21(27-23(30)33)26-20(25-19)16-6-8-17(9-7-16)36-15-18(31)28-11-13-29(14-12-28)24(34)35-4-2/h6-9H,3-5,10-15H2,1-2H3,(H,25,26)(H,27,33) |
| InChIKey | SAIMCJSPHKXHRK-UHFFFAOYSA-N |
| Mol Weight | 498.54 g/mol |
| Molecular Formula | C24H30N6O6 |
| Exact Mass | 498.222683 g/mol |
| Copyright | Copyright © 2016-2024 W. Robien, Inst. of Org. Chem., Univ. of Vienna. All Rights Reserved. |
|---|---|
| Solvent | DMSO-D6 |
1-BUTYL-8-[4-[(4-ACETYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-BENZYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-PHENYLPIPERAZIN-1-YL)-2-OXOETHOXY]-PHENYL]-XANTHINE
1-BUTYL-8-[4-[(4-CARBOXYMETHYL)-PHENYLAMINO-2-OXOETHOXY]-PHENYL]-XANTHINE
8-(2-furanyl)-1,3-dimethyl-7H-purine-2,6-dione
3-(3,4-Dimethoxyphenyl)-6-methylpyrimido[5,4-E][1,2,4]triazine-5,7(6H,8H)-dione
8-Butyl-9-(2-hydroxyethyl)-1-methyl-3H-purine-2,6-dione
8-Propyl-1-methyl-9-(2'-hydroxyethyl)-9H-purine-2,6(1H,3H)-dione
2-chloranyl-N-[1,3-dimethyl-2,6-bis(oxidanylidene)-7H-purin-8-yl]benzamide
2-[(1',3'-Dimethyl-2',4'-dioxopurin-8'-yl)hydrazono]-2-(4"-methoxyphenyl)acetic acid
| Title | Journal or Book | Year |
|---|---|---|
| 1,8-Disubstituted Xanthine Derivatives: Synthesis of Potent A2B-Selective Adenosine Receptor Antagonists | Journal of Medicinal Chemistry | 2002 |